File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/cam4.65
- PMID: 23930208
- WOS: WOS:000209210700006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A phase I study of ABT-510 plus bevacizumab in advanced solid tumors
Title | A phase I study of ABT-510 plus bevacizumab in advanced solid tumors |
---|---|
Authors | |
Issue Date | 2013 |
Publisher | John Wiley & Sons Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2045-7634 |
Citation | Cancer Medicine, 2013, v. 2 n. 3, p. 316-324 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/195024 |
ISSN | 2023 Impact Factor: 2.9 2023 SCImago Journal Rankings: 1.174 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Uronis, HE | en_US |
dc.contributor.author | Cushman, SM | en_US |
dc.contributor.author | Bendell, JC | en_US |
dc.contributor.author | Blobe, GC | en_US |
dc.contributor.author | Morse, MA | en_US |
dc.contributor.author | Nixon, AB | en_US |
dc.contributor.author | Dellinger, A | en_US |
dc.contributor.author | Starr, MD | en_US |
dc.contributor.author | Li, H | en_US |
dc.contributor.author | Meadows, K | en_US |
dc.contributor.author | Gockerman, J | en_US |
dc.contributor.author | Pang, HMH | en_US |
dc.contributor.author | Hurwitz, HI | en_US |
dc.date.accessioned | 2014-02-21T06:50:02Z | - |
dc.date.available | 2014-02-21T06:50:02Z | - |
dc.date.issued | 2013 | en_US |
dc.identifier.citation | Cancer Medicine, 2013, v. 2 n. 3, p. 316-324 | en_US |
dc.identifier.issn | 2045-7634 | - |
dc.identifier.uri | http://hdl.handle.net/10722/195024 | - |
dc.language | eng | en_US |
dc.publisher | John Wiley & Sons Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2045-7634 | - |
dc.relation.ispartof | Cancer Medicine | en_US |
dc.rights | Cancer Medicine. Copyright © John Wiley & Sons Ltd. | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | A phase I study of ABT-510 plus bevacizumab in advanced solid tumors | en_US |
dc.type | Article | en_US |
dc.identifier.email | Pang, HMH: herbpang@hku.hk | en_US |
dc.identifier.authority | Pang, HMH=rp01857 | en_US |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1002/cam4.65 | en_US |
dc.identifier.pmid | 23930208 | - |
dc.identifier.pmcid | PMC3699843 | - |
dc.identifier.hkuros | 228013 | en_US |
dc.identifier.volume | 2 | en_US |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 316 | en_US |
dc.identifier.epage | 324 | en_US |
dc.identifier.isi | WOS:000209210700006 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 2045-7634 | - |